Im vergangenen Jahr erzielte Sonoma Pharmaceuticals Inc für sein leistungsstärkstes Segment, Human Care, Einnahmen von 17.68M USD. Die Region Europe leistete den größten Beitrag mit 6.90M USD im letzten Jahr. Im letzten Quartal berichtete Sonoma Pharmaceuticals Inc über Einnahmen in Höhe von 5.97M USD für den Zeitraum bis zum 2026-06-30, die aus dem leistungsstärksten Segment, Human Care, stammten. United States trug mit 2.43M USD den höchsten Umsatz bei.

Nach Geschäftsbereich

Umsatz

Anteil

Jährlich

Jährlich

Vierteljährlich

Human Care

Animal Care

Service and Royalty

Service

FY2026

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

Human Care

17.68M(90.54%)

12.08M(84.54%)

10.11M(79.39%)

9.43M(71.02%)

9.01M(71.35%)

15.32M(82.22%)

15.69M(87.49%)

15.91M(83.88%)

Animal Care

1.85M(9.46%)

1.65M(11.57%)

2.20M(17.30%)

2.50M(18.84%)

3.17M(25.10%)

3.20M(17.18%)

2.09M(11.66%)

1.97M(10.38%)

Service and Royalty

--(--)

556.00K(3.89%)

422.00K(3.31%)

1.35M(10.14%)

449.00K(3.56%)

--(--)

Service

--(--)

112.00K(0.60%)

151.00K(0.84%)

1.09M(5.74%)

Nach Region

Umsatz

Anteil

Jährlich

Jährlich

Vierteljährlich

Europe

United States

Asia

Latin America

Rest of the world

Europe

Asia

Europe and Rest of the World

Service Revenues

Product license fees and royalties

FY2026

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

FY2014

FY2013

FY2012

Europe

6.90M(35.35%)

--(--)

United States

5.67M(29.05%)

2.61M(18.27%)

3.06M(24.01%)

3.43M(25.83%)

3.81M(30.15%)

5.42M(29.09%)

7.99M(44.57%)

9.04M(47.65%)

8.37M(53.45%)

6.58M(51.31%)

4.37M(31.17%)

1.98M(15.22%)

1.41M(11.05%)

6.84M(44.28%)

4.72M(37.01%)

Asia

2.90M(14.85%)

--(--)

Latin America

2.37M(12.15%)

2.96M(20.73%)

1.73M(13.55%)

2.38M(17.96%)

2.10M(16.59%)

5.98M(32.08%)

3.77M(21.05%)

3.96M(20.89%)

3.01M(19.20%)

1.30M(10.13%)

4.96M(35.41%)

5.05M(38.88%)

3.76M(29.54%)

5.89M(38.09%)

5.19M(40.73%)

Rest of the world

1.68M(8.59%)

875.00K(6.12%)

872.00K(6.85%)

959.00K(7.23%)

--(--)

Europe

--(--)

5.52M(38.65%)

4.78M(37.54%)

4.05M(30.52%)

--(--)

Asia

--(--)

2.32M(16.22%)

2.30M(18.04%)

2.45M(18.47%)

--(--)

Europe and Rest of the World

--(--)

6.73M(53.26%)

7.23M(38.83%)

6.16M(34.38%)

4.88M(25.72%)

4.28M(27.35%)

4.08M(31.80%)

3.71M(26.43%)

2.91M(22.38%)

2.05M(16.08%)

1.85M(12.00%)

1.95M(15.28%)

Service Revenues

--(--)

1.09M(5.74%)

--(--)

868.00K(6.77%)

981.00K(7.00%)

3.06M(23.52%)

5.51M(43.33%)

869.00K(5.62%)

891.00K(6.99%)

Product license fees and royalties

--(--)